Clinical Efficacy of Tolterodine Extended Release is Maintained for 24 Hours in Patients with Overactive Bladder
Dmochowski R1, Guan Z2, Carlsson M2, Nitti V3 1. Vanderbilt University Medical Center, 2. Pfizer, Inc, 3. New York University Medical Center
|
|
Abstract 136
|
|
|
Non Discussion Posters
Scientific Non Discussion Poster Session 17
|
|
|